ZEMCELPRO

This brand name is authorized in Austria, Estonia, France, Italy, Lithuania.

Active ingredients

The drug ZEMCELPRO contains a combination of these active pharmaceutical ingredients (APIs):

1	Dorocubicel UNII DBD2HM3I4V - DOROCUBICEL
2	Unexpanded CD34- cells

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZEMCELPRO Dispersion for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05AX04		B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AX Other blood products
Discover more medicines within B05AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3133448
FR	Base de données publique des médicaments	62150245
IT	Agenzia del Farmaco	052495013
LT	Valstybinė vaistų kontrolės tarnyba	1104529